Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05435989 · ClinicalTrials.gov registry record · NA
Extended High-frequency Hearing and Speech Perception
A NA study of Low-pass Filtering Speech, sponsored by Brian Monson.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT05435989 is a NA study of Low-pass Filtering Speech that is actively recruiting participants, run by Brian Monson. The registered enrollment target is 480 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05435989, a NA study of Low-pass Filtering Speech, is actively recruiting participants, sponsored by Brian Monson.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the effects of low-pass filtering speech on speech perception.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Reduced extended high-frequency audibility
Study Locations (1)
Illinois
- University of Illinois Urbana-Champaign - Champaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2021-11-09 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05435989
The ClinicalTrials.gov registry entry for NCT05435989 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brian Monson, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Low-pass Filtering Speech appearing as the primary indexed condition, and to 1 intervention - of which Reduced extended high-frequency audibility is the first listed.
NCT05435989 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05435989 about?
NCT05435989 is a clinical study titled "Extended High-frequency Hearing and Speech Perception". This study examines the effects of low-pass filtering speech on speech perception.
What is the current status of trial NCT05435989?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2021-11-09. Estimated completion is 2026-06.
What conditions does trial NCT05435989 study?
This clinical trial studies the following conditions: Low-pass Filtering Speech.
What interventions are being tested in trial NCT05435989?
The interventions under investigation include: Reduced extended high-frequency audibility (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05435989?
This trial is sponsored by Brian Monson, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05435989 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.